• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

开发门诊肠外抗菌治疗患者 30 天内非计划性住院风险预测模型。

Developing a risk prediction model for 30-day unplanned hospitalization in patients receiving outpatient parenteral antimicrobial therapy.

机构信息

Department of Infection and Tropical Medicine, Royal Hallamshire Hospital, Sheffield, UK.

Department of Epidemiology and Medical Statistics, School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, UK.

出版信息

Clin Microbiol Infect. 2019 Jul;25(7):905.e1-905.e7. doi: 10.1016/j.cmi.2018.11.009. Epub 2018 Nov 28.

DOI:10.1016/j.cmi.2018.11.009
PMID:30502491
Abstract

OBJECTIVES

Outpatient parenteral antimicrobial therapy (OPAT) is increasingly used to treat a wide range of infections. However, there is risk of hospital readmissions. The study aim was to develop a prediction model for the risk of 30-day unplanned hospitalization in patients receiving OPAT.

METHODS

Using a retrospective cohort design, we retrieved data on 1073 patients who received OPAT over 2 years (January 2015 to January 2017) at a large teaching hospital in Sheffield, UK. We developed a multivariable logistic regression model for 30-day unplanned hospitalization, assessed its discrimination and calibration abilities, and internally them validated using bootstrap resampling.

RESULTS

The 30-day unplanned hospitalization rate was 11% (123/1073). The main indication for hospitalization was worsening or nonresponse of infection (52/123, 42%). The final regression model consisted of age (adjusted odds ratio (aOR), 1.18 per decade; 95% confidence interval (CI), 1.04-1.34), Charlson comorbidity score (aOR, 1.11 per unit increase; 95% CI, 1.00-1.23), prior hospitalizations in past 12 months (aOR, 1.30 per admission; 95% CI, 1.17-1.45), concurrent intravenous antimicrobial therapy (aOR, 1.89; 95% CI, 1.03-3.47) and endovascular infection (aOR, 3.51; 95% CI, 1.49-8.28). Mode of OPAT treatment was retained in the model as a confounder. The model had adequate concordance (c-statistic 0.72; 95% CI 0.67-0.77) and calibration (Hosmer-Lemeshow p 0.546; calibration slope 0.99; 95% CI 0.78-1.21), and low degree of optimism (bootstrap optimism corrected c-statistic, 0.70).

CONCLUSIONS

We identified a set of six important predictors of unplanned hospitalization based on readily available data. The prediction model may help improve OPAT outcomes through better identification of high-risk patients and provision of tailored care.

摘要

目的

门诊静脉输注抗菌药物治疗(OPAT)被广泛应用于多种感染的治疗。然而,OPAT 存在导致患者再次住院的风险。本研究旨在建立一个预测模型,用于预测接受 OPAT 治疗的患者在 30 天内非计划性住院的风险。

方法

采用回顾性队列设计,我们从英国谢菲尔德一家大型教学医院的数据库中提取了 2015 年 1 月至 2017 年 1 月期间接受 OPAT 治疗的 1073 例患者的数据。我们建立了一个用于预测 30 天内非计划性住院的多变量逻辑回归模型,评估了其区分度和校准能力,并通过 bootstrap 重采样进行内部验证。

结果

30 天内非计划性住院率为 11%(123/1073)。导致住院的主要原因为感染加重或无反应(52/123,42%)。最终的回归模型包含年龄(每十年校正优势比[aOR],1.18;95%置信区间[CI],1.04-1.34)、Charlson 合并症评分(每增加 1 分 aOR,1.11;95%CI,1.00-1.23)、过去 12 个月内的住院次数(每住院一次 aOR,1.30;95%CI,1.17-1.45)、同期静脉内使用抗菌药物治疗(aOR,1.89;95%CI,1.03-3.47)和血管内感染(aOR,3.51;95%CI,1.49-8.28)。OPAT 治疗模式作为混杂因素保留在模型中。该模型具有良好的一致性(c 统计量 0.72;95%CI,0.67-0.77)和校准度(Hosmer-Lemeshow p 值为 0.546;校准斜率为 0.99;95%CI,0.78-1.21),且具有较低的过度拟合程度(bootstrap 校正后 c 统计量为 0.70)。

结论

我们根据易于获得的数据确定了一组 6 个重要的非计划性住院预测因子。该预测模型可通过更好地识别高危患者并提供个体化治疗,从而改善 OPAT 结局。

相似文献

1
Developing a risk prediction model for 30-day unplanned hospitalization in patients receiving outpatient parenteral antimicrobial therapy.开发门诊肠外抗菌治疗患者 30 天内非计划性住院风险预测模型。
Clin Microbiol Infect. 2019 Jul;25(7):905.e1-905.e7. doi: 10.1016/j.cmi.2018.11.009. Epub 2018 Nov 28.
2
External validity and clinical usefulness of a risk prediction model for 30 day unplanned hospitalization in patients receiving outpatient parenteral antimicrobial therapy.接受门诊肠外抗菌治疗患者 30 天内非计划性住院风险预测模型的外部有效性和临床实用性。
J Antimicrob Chemother. 2021 Jul 15;76(8):2204-2212. doi: 10.1093/jac/dkab127.
3
Prediction model for 30-day hospital readmissions among patients discharged receiving outpatient parenteral antibiotic therapy.接受门诊胃肠外抗生素治疗出院患者30天内再入院的预测模型
Clin Infect Dis. 2014 Mar;58(6):812-9. doi: 10.1093/cid/cit920. Epub 2013 Dec 19.
4
Clinical predictors of outcome in patients with infective endocarditis receiving outpatient parenteral antibiotic therapy (OPAT).接受门诊胃肠外抗生素治疗(OPAT)的感染性心内膜炎患者预后的临床预测因素。
J Infect. 2021 Dec;83(6):644-649. doi: 10.1016/j.jinf.2021.09.021. Epub 2021 Oct 3.
5
Electronic health record-based readmission risk model performance for patients undergoing outpatient parenteral antibiotic therapy (OPAT).基于电子健康记录的门诊静脉抗生素治疗(OPAT)患者再入院风险模型的性能
PLOS Digit Health. 2023 Aug 2;2(8):e0000323. doi: 10.1371/journal.pdig.0000323. eCollection 2023 Aug.
6
Association of laboratory test result availability and rehospitalizations in an outpatient parenteral antimicrobial therapy programme.实验室检验结果可得性与门诊肠外抗菌治疗方案再入院的关联。
J Antimicrob Chemother. 2014 Jan;69(1):228-33. doi: 10.1093/jac/dkt303. Epub 2013 Jul 25.
7
Inequitable access to an outpatient parenteral antimicrobial therapy service: linked cross-sectional study.门诊肠外抗菌治疗服务可及性的不公平:关联横断面研究。
Int J Equity Health. 2020 Sep 1;19(1):150. doi: 10.1186/s12939-020-01261-w.
8
Close Patient Follow-up Among Patients Receiving Outpatient Parenteral Antimicrobial Therapy.密切门诊肠外抗菌治疗患者的随访。
Clin Infect Dis. 2020 Jan 1;70(1):67-74. doi: 10.1093/cid/ciz150.
9
Clinical characteristics and outcomes of patients receiving outpatient parenteral antibiotic therapy in a Belgian setting: a single-center pilot study.比利时门诊接受胃肠外抗生素治疗患者的临床特征及治疗结果:一项单中心试点研究
Acta Clin Belg. 2020 Aug;75(4):275-283. doi: 10.1080/17843286.2019.1608396. Epub 2019 Apr 25.
10
Retrospective analysis of outcomes of outpatient parenteral antimicrobial therapy (OPAT) for necrotising otitis externa.回顾性分析门诊患者接受局部抗菌治疗(OPAT)治疗坏死性外耳道炎的结果。
Eur J Clin Microbiol Infect Dis. 2022 Jun;41(6):941-949. doi: 10.1007/s10096-022-04455-y. Epub 2022 May 13.

引用本文的文献

1
Risk of Treatment Failure in Outpatient Parenteral Antimicrobial Therapy From an Academic Medical Center in Kentucky.肯塔基州一家学术医疗中心门诊胃肠外抗菌治疗的治疗失败风险
Open Forum Infect Dis. 2025 Aug 1;12(8):ofaf459. doi: 10.1093/ofid/ofaf459. eCollection 2025 Aug.
2
Delivery of Outpatient Parenteral Antimicrobial Therapy (OPAT) in an Ever-Changing National Health Service (UK): Benefits, Barriers, and Opportunities.在不断变化的英国国民医疗服务体系中提供门诊肠外抗菌治疗(OPAT):益处、障碍与机遇
Antibiotics (Basel). 2025 Apr 29;14(5):451. doi: 10.3390/antibiotics14050451.
3
Impact of a nurse practitioner-led dedicated outpatient parenteral antibiotic therapy clinic on patient outcomes and administrative workload: a retrospective cohort study.
执业护士主导的门诊专用肠外抗生素治疗诊所对患者预后及行政工作量的影响:一项回顾性队列研究
Ther Adv Infect Dis. 2024 Dec 23;11:20499361241305308. doi: 10.1177/20499361241305308. eCollection 2024 Jan-Dec.
4
An evaluation of risk factors for readmission in patients receiving outpatient parenteral antimicrobial therapy.接受门诊胃肠外抗菌治疗患者再入院风险因素的评估。
Ther Adv Infect Dis. 2023 Sep 1;10:20499361231195966. doi: 10.1177/20499361231195966. eCollection 2023 Jan-Dec.
5
Electronic health record-based readmission risk model performance for patients undergoing outpatient parenteral antibiotic therapy (OPAT).基于电子健康记录的门诊静脉抗生素治疗(OPAT)患者再入院风险模型的性能
PLOS Digit Health. 2023 Aug 2;2(8):e0000323. doi: 10.1371/journal.pdig.0000323. eCollection 2023 Aug.
6
Decreased hospital readmissions after programmatic strengthening of an outpatient parenteral antimicrobial therapy (OPAT) program.在对门诊胃肠外抗菌治疗(OPAT)项目进行系统性强化后,医院再入院率降低。
Antimicrob Steward Healthc Epidemiol. 2023 Feb 21;3(1):e33. doi: 10.1017/ash.2022.330. eCollection 2023.
7
Utility of a risk assessment model in predicting 30 day unplanned hospital readmission in adult patients receiving outpatient parenteral antimicrobial therapy.风险评估模型在预测接受门诊胃肠外抗菌治疗的成年患者30天非计划再次住院中的效用。
JAC Antimicrob Resist. 2023 Feb 21;5(1):dlad019. doi: 10.1093/jacamr/dlad019. eCollection 2023 Feb.
8
Impact of a Pharmacist-Managed Outpatient Parenteral Antimicrobial Therapy (OPAT) Service on Cost Savings and Clinical Outcomes at an Academic Medical Center.药师管理的门诊胃肠外抗菌治疗(OPAT)服务对一所学术医疗中心成本节约和临床结局的影响
Antimicrob Steward Healthc Epidemiol. 2023 Jan 17;3(1):e15. doi: 10.1017/ash.2022.374. eCollection 2023.
9
Outcomes among patients with bacteremia enrolled in a postdischarge outpatient parenteral antibiotic therapy program at an academic medical center.在一家学术医疗中心参加出院后门诊胃肠外抗生素治疗项目的菌血症患者的治疗结果。
Antimicrob Steward Healthc Epidemiol. 2022 Oct 10;2(1):e167. doi: 10.1017/ash.2022.302. eCollection 2022.
10
Outpatient Parenteral Antimicrobial Therapy Practice in United Kingdom: A Single-center Experience.英国门诊胃肠外抗菌治疗实践:单中心经验
Oman Med J. 2022 Nov 30;37(6):e442. doi: 10.5001/omj.2023.26. eCollection 2022 Nov.